nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—Estropipate—osteoporosis	0.28	0.707	CbGbCtD
Auranofin—ALB—Estradiol—osteoporosis	0.116	0.293	CbGbCtD
Auranofin—Melaena—Alendronate—osteoporosis	0.00334	0.0113	CcSEcCtD
Auranofin—Haematuria—Calcium Acetate—osteoporosis	0.00326	0.011	CcSEcCtD
Auranofin—Weight decreased—Ergocalciferol—osteoporosis	0.00306	0.0104	CcSEcCtD
Auranofin—Glossitis—Risedronate—osteoporosis	0.00297	0.0101	CcSEcCtD
Auranofin—Proteinuria—Zoledronate—osteoporosis	0.00271	0.00917	CcSEcCtD
Auranofin—Protein urine present—Zoledronate—osteoporosis	0.00267	0.00904	CcSEcCtD
Auranofin—Dysgeusia—Calcium Acetate—osteoporosis	0.00261	0.00885	CcSEcCtD
Auranofin—Pancytopenia—Etidronic acid—osteoporosis	0.00239	0.00809	CcSEcCtD
Auranofin—Neuropathy peripheral—Etidronic acid—osteoporosis	0.0022	0.00744	CcSEcCtD
Auranofin—Anaemia—Ergocalciferol—osteoporosis	0.00218	0.00738	CcSEcCtD
Auranofin—Dysphagia—Alendronate—osteoporosis	0.00214	0.00725	CcSEcCtD
Auranofin—Agranulocytosis—Etidronic acid—osteoporosis	0.00209	0.00708	CcSEcCtD
Auranofin—Dysphagia—Ibandronate—osteoporosis	0.00209	0.00706	CcSEcCtD
Auranofin—Anorexia—Calcium Acetate—osteoporosis	0.00208	0.00703	CcSEcCtD
Auranofin—Neuropathy peripheral—Estropipate—osteoporosis	0.0019	0.00644	CcSEcCtD
Auranofin—Decreased appetite—Calcium Acetate—osteoporosis	0.00189	0.00641	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.00189	0.0064	CcSEcCtD
Auranofin—Weight decreased—Ibandronate—osteoporosis	0.00189	0.00639	CcSEcCtD
Auranofin—Constipation—Calcium Acetate—osteoporosis	0.00186	0.00631	CcSEcCtD
Auranofin—Stomatitis—Alendronate—osteoporosis	0.00186	0.00631	CcSEcCtD
Auranofin—Weight decreased—Calcitriol—osteoporosis	0.00185	0.00626	CcSEcCtD
Auranofin—Anorexia—Ergocalciferol—osteoporosis	0.00183	0.00621	CcSEcCtD
Auranofin—Conjunctivitis—Raloxifene—osteoporosis	0.00183	0.00618	CcSEcCtD
Auranofin—Stomatitis—Ibandronate—osteoporosis	0.00181	0.00614	CcSEcCtD
Auranofin—Alopecia—Etidronic acid—osteoporosis	0.00178	0.00602	CcSEcCtD
Auranofin—Conjunctivitis—Calcitriol—osteoporosis	0.00177	0.00599	CcSEcCtD
Auranofin—Flatulence—Etidronic acid—osteoporosis	0.00173	0.00585	CcSEcCtD
Auranofin—Visual impairment—Estropipate—osteoporosis	0.00168	0.00568	CcSEcCtD
Auranofin—Decreased appetite—Ergocalciferol—osteoporosis	0.00167	0.00566	CcSEcCtD
Auranofin—Constipation—Ergocalciferol—osteoporosis	0.00165	0.00557	CcSEcCtD
Auranofin—Eye disorder—Estropipate—osteoporosis	0.00163	0.00551	CcSEcCtD
Auranofin—Anaemia—Etidronic acid—osteoporosis	0.00162	0.00548	CcSEcCtD
Auranofin—Angioedema—Etidronic acid—osteoporosis	0.0016	0.00542	CcSEcCtD
Auranofin—Weight decreased—Ethinyl Estradiol—osteoporosis	0.0016	0.0054	CcSEcCtD
Auranofin—Leukopenia—Etidronic acid—osteoporosis	0.00157	0.00531	CcSEcCtD
Auranofin—Eye disorder—Ibandronate—osteoporosis	0.00156	0.00528	CcSEcCtD
Auranofin—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.00154	0.00522	CcSEcCtD
Auranofin—Pruritus—Calcium Acetate—osteoporosis	0.00154	0.00522	CcSEcCtD
Auranofin—Alopecia—Estropipate—osteoporosis	0.00154	0.00521	CcSEcCtD
Auranofin—Neutropenia—Pamidronate—osteoporosis	0.00153	0.00517	CcSEcCtD
Auranofin—Alopecia—Alendronate—osteoporosis	0.00152	0.00513	CcSEcCtD
Auranofin—Flatulence—Estropipate—osteoporosis	0.00149	0.00506	CcSEcCtD
Auranofin—Dysphagia—Zoledronate—osteoporosis	0.00149	0.00505	CcSEcCtD
Auranofin—Diarrhoea—Calcium Acetate—osteoporosis	0.00149	0.00505	CcSEcCtD
Auranofin—Conjunctivitis—Risedronate—osteoporosis	0.00149	0.00505	CcSEcCtD
Auranofin—Alopecia—Ibandronate—osteoporosis	0.00148	0.005	CcSEcCtD
Auranofin—Flatulence—Alendronate—osteoporosis	0.00147	0.00498	CcSEcCtD
Auranofin—Dysgeusia—Alendronate—osteoporosis	0.00146	0.00495	CcSEcCtD
Auranofin—Flatulence—Raloxifene—osteoporosis	0.00145	0.0049	CcSEcCtD
Auranofin—Dysphagia—Conjugated Estrogens—osteoporosis	0.00144	0.00487	CcSEcCtD
Auranofin—Flatulence—Ibandronate—osteoporosis	0.00143	0.00485	CcSEcCtD
Auranofin—Dysgeusia—Ibandronate—osteoporosis	0.00142	0.00482	CcSEcCtD
Auranofin—Stomatitis—Pamidronate—osteoporosis	0.00142	0.00481	CcSEcCtD
Auranofin—Pancytopenia—Zoledronate—osteoporosis	0.00142	0.0048	CcSEcCtD
Auranofin—Conjunctivitis—Pamidronate—osteoporosis	0.00142	0.0048	CcSEcCtD
Auranofin—Neutropenia—Zoledronate—osteoporosis	0.0014	0.00473	CcSEcCtD
Auranofin—Dysgeusia—Calcitriol—osteoporosis	0.00139	0.00472	CcSEcCtD
Auranofin—Haematuria—Pamidronate—osteoporosis	0.00139	0.0047	CcSEcCtD
Auranofin—Angioedema—Estropipate—osteoporosis	0.00139	0.00469	CcSEcCtD
Auranofin—Vomiting—Calcium Acetate—osteoporosis	0.00139	0.00469	CcSEcCtD
Auranofin—Anaemia—Alendronate—osteoporosis	0.00138	0.00467	CcSEcCtD
Auranofin—Angioedema—Alendronate—osteoporosis	0.00136	0.00462	CcSEcCtD
Auranofin—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00136	0.00461	CcSEcCtD
Auranofin—Agranulocytosis—Pamidronate—osteoporosis	0.00136	0.0046	CcSEcCtD
Auranofin—Weight decreased—Zoledronate—osteoporosis	0.00135	0.00457	CcSEcCtD
Auranofin—Anaemia—Ibandronate—osteoporosis	0.00134	0.00455	CcSEcCtD
Auranofin—Angioedema—Ibandronate—osteoporosis	0.00133	0.0045	CcSEcCtD
Auranofin—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00132	0.00447	CcSEcCtD
Auranofin—Stomatitis—Zoledronate—osteoporosis	0.0013	0.00439	CcSEcCtD
Auranofin—Conjunctivitis—Zoledronate—osteoporosis	0.00129	0.00438	CcSEcCtD
Auranofin—Nausea—Calcium Acetate—osteoporosis	0.00129	0.00438	CcSEcCtD
Auranofin—Eye disorder—Risedronate—osteoporosis	0.00129	0.00435	CcSEcCtD
Auranofin—Haematuria—Zoledronate—osteoporosis	0.00127	0.0043	CcSEcCtD
Auranofin—Dyspepsia—Etidronic acid—osteoporosis	0.00126	0.00426	CcSEcCtD
Auranofin—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.00126	0.00425	CcSEcCtD
Auranofin—Alopecia—Ethinyl Estradiol—osteoporosis	0.00125	0.00422	CcSEcCtD
Auranofin—Agranulocytosis—Zoledronate—osteoporosis	0.00124	0.00421	CcSEcCtD
Auranofin—Constipation—Etidronic acid—osteoporosis	0.00122	0.00414	CcSEcCtD
Auranofin—Eye disorder—Pamidronate—osteoporosis	0.00122	0.00414	CcSEcCtD
Auranofin—Flatulence—Risedronate—osteoporosis	0.00118	0.004	CcSEcCtD
Auranofin—Thrombocytopenia—Raloxifene—osteoporosis	0.00117	0.00397	CcSEcCtD
Auranofin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00117	0.00396	CcSEcCtD
Auranofin—Alopecia—Pamidronate—osteoporosis	0.00116	0.00391	CcSEcCtD
Auranofin—Dysphagia—Estradiol—osteoporosis	0.00115	0.0039	CcSEcCtD
Auranofin—Nausea—Ergocalciferol—osteoporosis	0.00114	0.00387	CcSEcCtD
Auranofin—Urticaria—Etidronic acid—osteoporosis	0.00114	0.00385	CcSEcCtD
Auranofin—Abdominal pain—Etidronic acid—osteoporosis	0.00113	0.00383	CcSEcCtD
Auranofin—Angioedema—Ethinyl Estradiol—osteoporosis	0.00112	0.0038	CcSEcCtD
Auranofin—Eye disorder—Zoledronate—osteoporosis	0.00112	0.00378	CcSEcCtD
Auranofin—Dysgeusia—Pamidronate—osteoporosis	0.00112	0.00378	CcSEcCtD
Auranofin—Visual impairment—Conjugated Estrogens—osteoporosis	0.00111	0.00375	CcSEcCtD
Auranofin—Anaemia—Risedronate—osteoporosis	0.00111	0.00375	CcSEcCtD
Auranofin—Anorexia—Calcitriol—osteoporosis	0.00111	0.00375	CcSEcCtD
Auranofin—Angioedema—Risedronate—osteoporosis	0.00109	0.00371	CcSEcCtD
Auranofin—Dyspepsia—Estropipate—osteoporosis	0.00109	0.00369	CcSEcCtD
Auranofin—Eye disorder—Conjugated Estrogens—osteoporosis	0.00108	0.00364	CcSEcCtD
Auranofin—Dyspepsia—Alendronate—osteoporosis	0.00107	0.00363	CcSEcCtD
Auranofin—Constipation—Estropipate—osteoporosis	0.00106	0.00358	CcSEcCtD
Auranofin—Alopecia—Zoledronate—osteoporosis	0.00106	0.00358	CcSEcCtD
Auranofin—Dyspepsia—Raloxifene—osteoporosis	0.00105	0.00357	CcSEcCtD
Auranofin—Anaemia—Pamidronate—osteoporosis	0.00105	0.00356	CcSEcCtD
Auranofin—Dyspepsia—Ibandronate—osteoporosis	0.00104	0.00354	CcSEcCtD
Auranofin—Constipation—Alendronate—osteoporosis	0.00104	0.00353	CcSEcCtD
Auranofin—Weight decreased—Estradiol—osteoporosis	0.00104	0.00352	CcSEcCtD
Auranofin—Angioedema—Pamidronate—osteoporosis	0.00104	0.00352	CcSEcCtD
Auranofin—Decreased appetite—Ibandronate—osteoporosis	0.00103	0.00349	CcSEcCtD
Auranofin—Leukopenia—Pamidronate—osteoporosis	0.00102	0.00345	CcSEcCtD
Auranofin—Dysgeusia—Zoledronate—osteoporosis	0.00102	0.00345	CcSEcCtD
Auranofin—Alopecia—Conjugated Estrogens—osteoporosis	0.00102	0.00344	CcSEcCtD
Auranofin—Constipation—Ibandronate—osteoporosis	0.00101	0.00343	CcSEcCtD
Auranofin—Pruritus—Etidronic acid—osteoporosis	0.00101	0.00343	CcSEcCtD
Auranofin—Gastrointestinal pain—Estropipate—osteoporosis	0.00101	0.00343	CcSEcCtD
Auranofin—Decreased appetite—Calcitriol—osteoporosis	0.00101	0.00342	CcSEcCtD
Auranofin—Neuropathy peripheral—Estradiol—osteoporosis	0.00101	0.0034	CcSEcCtD
Auranofin—Jaundice—Estradiol—osteoporosis	0.001	0.00339	CcSEcCtD
Auranofin—Conjunctivitis—Estradiol—osteoporosis	0.000997	0.00338	CcSEcCtD
Auranofin—Gastrointestinal pain—Alendronate—osteoporosis	0.000996	0.00337	CcSEcCtD
Auranofin—Constipation—Calcitriol—osteoporosis	0.000993	0.00336	CcSEcCtD
Auranofin—Flatulence—Conjugated Estrogens—osteoporosis	0.000987	0.00334	CcSEcCtD
Auranofin—Urticaria—Estropipate—osteoporosis	0.000983	0.00333	CcSEcCtD
Auranofin—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000981	0.00332	CcSEcCtD
Auranofin—Gastrointestinal pain—Raloxifene—osteoporosis	0.00098	0.00332	CcSEcCtD
Auranofin—Diarrhoea—Etidronic acid—osteoporosis	0.000978	0.00331	CcSEcCtD
Auranofin—Haematuria—Estradiol—osteoporosis	0.000978	0.00331	CcSEcCtD
Auranofin—Abdominal pain—Estropipate—osteoporosis	0.000978	0.00331	CcSEcCtD
Auranofin—Gastrointestinal pain—Ibandronate—osteoporosis	0.00097	0.00328	CcSEcCtD
Auranofin—Urticaria—Alendronate—osteoporosis	0.000968	0.00328	CcSEcCtD
Auranofin—Abdominal pain—Alendronate—osteoporosis	0.000963	0.00326	CcSEcCtD
Auranofin—Anaemia—Zoledronate—osteoporosis	0.000961	0.00326	CcSEcCtD
Auranofin—Angioedema—Zoledronate—osteoporosis	0.000951	0.00322	CcSEcCtD
Auranofin—Gastrointestinal pain—Calcitriol—osteoporosis	0.00095	0.00322	CcSEcCtD
Auranofin—Abdominal pain—Raloxifene—osteoporosis	0.000947	0.00321	CcSEcCtD
Auranofin—Urticaria—Ibandronate—osteoporosis	0.000943	0.00319	CcSEcCtD
Auranofin—Abdominal pain—Ibandronate—osteoporosis	0.000938	0.00318	CcSEcCtD
Auranofin—Leukopenia—Zoledronate—osteoporosis	0.000931	0.00315	CcSEcCtD
Auranofin—Urticaria—Calcitriol—osteoporosis	0.000923	0.00312	CcSEcCtD
Auranofin—Abdominal pain—Calcitriol—osteoporosis	0.000918	0.00311	CcSEcCtD
Auranofin—Angioedema—Conjugated Estrogens—osteoporosis	0.000915	0.0031	CcSEcCtD
Auranofin—Thrombocytopenia—Pamidronate—osteoporosis	0.00091	0.00308	CcSEcCtD
Auranofin—Vomiting—Etidronic acid—osteoporosis	0.000909	0.00308	CcSEcCtD
Auranofin—Rash—Etidronic acid—osteoporosis	0.000902	0.00305	CcSEcCtD
Auranofin—Dermatitis—Etidronic acid—osteoporosis	0.000901	0.00305	CcSEcCtD
Auranofin—Visual impairment—Estradiol—osteoporosis	0.000887	0.003	CcSEcCtD
Auranofin—Anorexia—Pamidronate—osteoporosis	0.000886	0.003	CcSEcCtD
Auranofin—Pruritus—Estropipate—osteoporosis	0.000875	0.00296	CcSEcCtD
Auranofin—Pruritus—Alendronate—osteoporosis	0.000862	0.00292	CcSEcCtD
Auranofin—Dyspepsia—Risedronate—osteoporosis	0.000861	0.00291	CcSEcCtD
Auranofin—Eye disorder—Estradiol—osteoporosis	0.000861	0.00291	CcSEcCtD
Auranofin—Constipation—Ethinyl Estradiol—osteoporosis	0.000858	0.0029	CcSEcCtD
Auranofin—Nausea—Etidronic acid—osteoporosis	0.000849	0.00288	CcSEcCtD
Auranofin—Diarrhoea—Estropipate—osteoporosis	0.000847	0.00287	CcSEcCtD
Auranofin—Pruritus—Ibandronate—osteoporosis	0.000839	0.00284	CcSEcCtD
Auranofin—Constipation—Risedronate—osteoporosis	0.000836	0.00283	CcSEcCtD
Auranofin—Diarrhoea—Alendronate—osteoporosis	0.000834	0.00282	CcSEcCtD
Auranofin—Thrombocytopenia—Zoledronate—osteoporosis	0.000831	0.00281	CcSEcCtD
Auranofin—Pruritus—Calcitriol—osteoporosis	0.000822	0.00278	CcSEcCtD
Auranofin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00082	0.00278	CcSEcCtD
Auranofin—Diarrhoea—Raloxifene—osteoporosis	0.00082	0.00278	CcSEcCtD
Auranofin—Dyspepsia—Pamidronate—osteoporosis	0.000818	0.00277	CcSEcCtD
Auranofin—Alopecia—Estradiol—osteoporosis	0.000814	0.00276	CcSEcCtD
Auranofin—Diarrhoea—Ibandronate—osteoporosis	0.000812	0.00275	CcSEcCtD
Auranofin—Anorexia—Zoledronate—osteoporosis	0.000809	0.00274	CcSEcCtD
Auranofin—Decreased appetite—Pamidronate—osteoporosis	0.000808	0.00274	CcSEcCtD
Auranofin—Gastrointestinal pain—Risedronate—osteoporosis	0.0008	0.00271	CcSEcCtD
Auranofin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000797	0.0027	CcSEcCtD
Auranofin—Constipation—Pamidronate—osteoporosis	0.000795	0.00269	CcSEcCtD
Auranofin—Diarrhoea—Calcitriol—osteoporosis	0.000795	0.00269	CcSEcCtD
Auranofin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000793	0.00268	CcSEcCtD
Auranofin—Flatulence—Estradiol—osteoporosis	0.00079	0.00267	CcSEcCtD
Auranofin—Vomiting—Estropipate—osteoporosis	0.000787	0.00266	CcSEcCtD
Auranofin—Dysgeusia—Estradiol—osteoporosis	0.000785	0.00266	CcSEcCtD
Auranofin—Rash—Estropipate—osteoporosis	0.00078	0.00264	CcSEcCtD
Auranofin—Dermatitis—Estropipate—osteoporosis	0.000779	0.00264	CcSEcCtD
Auranofin—Anorexia—Conjugated Estrogens—osteoporosis	0.000779	0.00264	CcSEcCtD
Auranofin—Urticaria—Risedronate—osteoporosis	0.000777	0.00263	CcSEcCtD
Auranofin—Vomiting—Alendronate—osteoporosis	0.000775	0.00262	CcSEcCtD
Auranofin—Abdominal pain—Risedronate—osteoporosis	0.000773	0.00262	CcSEcCtD
Auranofin—Rash—Alendronate—osteoporosis	0.000768	0.0026	CcSEcCtD
Auranofin—Dermatitis—Alendronate—osteoporosis	0.000768	0.0026	CcSEcCtD
Auranofin—Vomiting—Raloxifene—osteoporosis	0.000762	0.00258	CcSEcCtD
Auranofin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00076	0.00257	CcSEcCtD
Auranofin—Rash—Raloxifene—osteoporosis	0.000756	0.00256	CcSEcCtD
Auranofin—Dermatitis—Raloxifene—osteoporosis	0.000755	0.00256	CcSEcCtD
Auranofin—Vomiting—Ibandronate—osteoporosis	0.000754	0.00255	CcSEcCtD
Auranofin—Rash—Ibandronate—osteoporosis	0.000748	0.00253	CcSEcCtD
Auranofin—Dermatitis—Ibandronate—osteoporosis	0.000747	0.00253	CcSEcCtD
Auranofin—Dyspepsia—Zoledronate—osteoporosis	0.000747	0.00253	CcSEcCtD
Auranofin—Vomiting—Calcitriol—osteoporosis	0.000738	0.0025	CcSEcCtD
Auranofin—Decreased appetite—Zoledronate—osteoporosis	0.000738	0.0025	CcSEcCtD
Auranofin—Nausea—Estropipate—osteoporosis	0.000735	0.00249	CcSEcCtD
Auranofin—Abdominal pain—Pamidronate—osteoporosis	0.000735	0.00249	CcSEcCtD
Auranofin—Angioedema—Estradiol—osteoporosis	0.000733	0.00248	CcSEcCtD
Auranofin—Rash—Calcitriol—osteoporosis	0.000732	0.00248	CcSEcCtD
Auranofin—Dermatitis—Calcitriol—osteoporosis	0.000732	0.00248	CcSEcCtD
Auranofin—Constipation—Zoledronate—osteoporosis	0.000726	0.00246	CcSEcCtD
Auranofin—Nausea—Alendronate—osteoporosis	0.000724	0.00245	CcSEcCtD
Auranofin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00072	0.00244	CcSEcCtD
Auranofin—Nausea—Raloxifene—osteoporosis	0.000712	0.00241	CcSEcCtD
Auranofin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000711	0.00241	CcSEcCtD
Auranofin—Pruritus—Ethinyl Estradiol—osteoporosis	0.00071	0.0024	CcSEcCtD
Auranofin—Nausea—Ibandronate—osteoporosis	0.000705	0.00239	CcSEcCtD
Auranofin—Constipation—Conjugated Estrogens—osteoporosis	0.000699	0.00237	CcSEcCtD
Auranofin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000694	0.00235	CcSEcCtD
Auranofin—Pruritus—Risedronate—osteoporosis	0.000692	0.00234	CcSEcCtD
Auranofin—Nausea—Calcitriol—osteoporosis	0.00069	0.00234	CcSEcCtD
Auranofin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000686	0.00232	CcSEcCtD
Auranofin—Urticaria—Zoledronate—osteoporosis	0.000674	0.00228	CcSEcCtD
Auranofin—Abdominal pain—Zoledronate—osteoporosis	0.000671	0.00227	CcSEcCtD
Auranofin—Diarrhoea—Risedronate—osteoporosis	0.000669	0.00226	CcSEcCtD
Auranofin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000668	0.00226	CcSEcCtD
Auranofin—Pruritus—Pamidronate—osteoporosis	0.000658	0.00223	CcSEcCtD
Auranofin—Urticaria—Conjugated Estrogens—osteoporosis	0.000649	0.0022	CcSEcCtD
Auranofin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000646	0.00219	CcSEcCtD
Auranofin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000638	0.00216	CcSEcCtD
Auranofin—Diarrhoea—Pamidronate—osteoporosis	0.000636	0.00215	CcSEcCtD
Auranofin—Rash—Ethinyl Estradiol—osteoporosis	0.000632	0.00214	CcSEcCtD
Auranofin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000632	0.00214	CcSEcCtD
Auranofin—Vomiting—Risedronate—osteoporosis	0.000622	0.0021	CcSEcCtD
Auranofin—Rash—Risedronate—osteoporosis	0.000616	0.00209	CcSEcCtD
Auranofin—Dermatitis—Risedronate—osteoporosis	0.000616	0.00209	CcSEcCtD
Auranofin—Pruritus—Zoledronate—osteoporosis	0.000601	0.00203	CcSEcCtD
Auranofin—Nausea—Ethinyl Estradiol—osteoporosis	0.000596	0.00202	CcSEcCtD
Auranofin—Vomiting—Pamidronate—osteoporosis	0.000591	0.002	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRAK3—osteoporosis	0.000587	0.0019	CbGpPWpGaD
Auranofin—Rash—Pamidronate—osteoporosis	0.000586	0.00198	CcSEcCtD
Auranofin—ALB—Platelet degranulation—FGA—osteoporosis	0.000586	0.0019	CbGpPWpGaD
Auranofin—Dermatitis—Pamidronate—osteoporosis	0.000586	0.00198	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—LEP—osteoporosis	0.000582	0.00189	CbGpPWpGaD
Auranofin—Diarrhoea—Zoledronate—osteoporosis	0.000581	0.00197	CcSEcCtD
Auranofin—Nausea—Risedronate—osteoporosis	0.000581	0.00197	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—AGER—osteoporosis	0.000579	0.00188	CbGpPWpGaD
Auranofin—Pruritus—Conjugated Estrogens—osteoporosis	0.000578	0.00196	CcSEcCtD
Auranofin—Dyspepsia—Estradiol—osteoporosis	0.000576	0.00195	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—IRS1—osteoporosis	0.000575	0.00186	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—IRS1—osteoporosis	0.000575	0.00186	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—AGER—osteoporosis	0.000569	0.00185	CbGpPWpGaD
Auranofin—Decreased appetite—Estradiol—osteoporosis	0.000569	0.00193	CcSEcCtD
Auranofin—Constipation—Estradiol—osteoporosis	0.00056	0.00189	CcSEcCtD
Auranofin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000559	0.00189	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000558	0.00181	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—ESR1—osteoporosis	0.000555	0.0018	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000555	0.0018	CbGpPWpGaD
Auranofin—Nausea—Pamidronate—osteoporosis	0.000552	0.00187	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—AGER—osteoporosis	0.000546	0.00177	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PSMA2—osteoporosis	0.00054	0.00175	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PSMA5—osteoporosis	0.00054	0.00175	CbGpPWpGaD
Auranofin—Vomiting—Zoledronate—osteoporosis	0.00054	0.00183	CcSEcCtD
Auranofin—Rash—Zoledronate—osteoporosis	0.000535	0.00181	CcSEcCtD
Auranofin—Gastrointestinal pain—Estradiol—osteoporosis	0.000535	0.00181	CcSEcCtD
Auranofin—Dermatitis—Zoledronate—osteoporosis	0.000535	0.00181	CcSEcCtD
Auranofin—ALB—Platelet degranulation—FGB—osteoporosis	0.000533	0.00173	CbGpPWpGaD
Auranofin—Vomiting—Conjugated Estrogens—osteoporosis	0.00052	0.00176	CcSEcCtD
Auranofin—Urticaria—Estradiol—osteoporosis	0.00052	0.00176	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—IRS1—osteoporosis	0.000519	0.00168	CbGpPWpGaD
Auranofin—Abdominal pain—Estradiol—osteoporosis	0.000517	0.00175	CcSEcCtD
Auranofin—Rash—Conjugated Estrogens—osteoporosis	0.000515	0.00175	CcSEcCtD
Auranofin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000515	0.00174	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.000514	0.00167	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000511	0.00166	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000508	0.00165	CbGpPWpGaD
Auranofin—Nausea—Zoledronate—osteoporosis	0.000504	0.00171	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—AGER—osteoporosis	0.000491	0.00159	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6R—osteoporosis	0.000487	0.00158	CbGpPWpGaD
Auranofin—Nausea—Conjugated Estrogens—osteoporosis	0.000486	0.00164	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—PSMA5—osteoporosis	0.000477	0.00155	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PSMA2—osteoporosis	0.000477	0.00155	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—IL1B—osteoporosis	0.000475	0.00154	CbGpPWpGaD
Auranofin—Pruritus—Estradiol—osteoporosis	0.000463	0.00157	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—AGER—osteoporosis	0.000462	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—osteoporosis	0.000459	0.00149	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KL—osteoporosis	0.000457	0.00148	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.00045	0.00146	CbGpPWpGaD
Auranofin—Diarrhoea—Estradiol—osteoporosis	0.000448	0.00152	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—osteoporosis	0.000442	0.00143	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6R—osteoporosis	0.000441	0.00143	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RAP1A—osteoporosis	0.000441	0.00143	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000441	0.00143	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoporosis	0.000439	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—IGF1—osteoporosis	0.000439	0.00142	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6R—osteoporosis	0.000437	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KL—osteoporosis	0.000436	0.00142	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6R—osteoporosis	0.000429	0.00139	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—osteoporosis	0.000428	0.00139	CbGpPWpGaD
Auranofin—Vomiting—Estradiol—osteoporosis	0.000416	0.00141	CcSEcCtD
Auranofin—ALB—Folate Metabolism—SOD2—osteoporosis	0.000415	0.00135	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6R—osteoporosis	0.000414	0.00134	CbGpPWpGaD
Auranofin—Rash—Estradiol—osteoporosis	0.000413	0.0014	CcSEcCtD
Auranofin—Dermatitis—Estradiol—osteoporosis	0.000412	0.0014	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—AGER—osteoporosis	0.000411	0.00133	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6R—osteoporosis	0.000407	0.00132	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KL—osteoporosis	0.000404	0.00131	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000403	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.000401	0.0013	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—osteoporosis	0.000398	0.00129	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—GPX1—osteoporosis	0.000396	0.00129	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6R—osteoporosis	0.00039	0.00127	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—SPP1—osteoporosis	0.00039	0.00126	CbGpPWpGaD
Auranofin—Nausea—Estradiol—osteoporosis	0.000389	0.00132	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—IL1B—osteoporosis	0.000371	0.0012	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TGFB1—osteoporosis	0.000369	0.0012	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000366	0.00119	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6R—osteoporosis	0.000364	0.00118	CbGpPWpGaD
Auranofin—ALB—Hemostasis—WDR1—osteoporosis	0.000362	0.00117	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—IRS2—osteoporosis	0.000353	0.00114	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6R—osteoporosis	0.000351	0.00114	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000347	0.00113	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—osteoporosis	0.000345	0.00112	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—osteoporosis	0.000345	0.00112	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000343	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6R—osteoporosis	0.00033	0.00107	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.00033	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRAK3—osteoporosis	0.000329	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IRS2—osteoporosis	0.000324	0.00105	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL1B—osteoporosis	0.000321	0.00104	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—osteoporosis	0.000316	0.00103	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000315	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—IRS2—osteoporosis	0.000313	0.00102	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—IRS1—osteoporosis	0.000308	0.000999	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ACTG1—osteoporosis	0.000301	0.000976	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IRS2—osteoporosis	0.000299	0.00097	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KL—osteoporosis	0.000297	0.000964	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6R—osteoporosis	0.000294	0.000954	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000291	0.000942	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.00029	0.00094	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000288	0.000934	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000286	0.000929	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAP1—osteoporosis	0.000286	0.000928	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IRS1—osteoporosis	0.000283	0.000918	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL1B—osteoporosis	0.000277	0.000898	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—IRS2—osteoporosis	0.000277	0.000898	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—IRS1—osteoporosis	0.000274	0.000887	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000273	0.000885	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000267	0.000865	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—osteoporosis	0.000264	0.000856	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoporosis	0.000263	0.000854	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IRS1—osteoporosis	0.000261	0.000847	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.00026	0.000843	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTSK—osteoporosis	0.000249	0.000809	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—osteoporosis	0.000249	0.000808	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoporosis	0.000246	0.000797	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—osteoporosis	0.000246	0.000797	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFATC1—osteoporosis	0.000245	0.000796	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6R—osteoporosis	0.000245	0.000795	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—IRS1—osteoporosis	0.000242	0.000784	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RAP1A—osteoporosis	0.000242	0.000783	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—IGF1—osteoporosis	0.000241	0.000782	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTSK—osteoporosis	0.00024	0.000777	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000236	0.000767	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—osteoporosis	0.000235	0.000763	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ADCY5—osteoporosis	0.000233	0.000755	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.00023	0.000745	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—osteoporosis	0.000229	0.000741	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MGLL—osteoporosis	0.000227	0.000737	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.000226	0.000734	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoporosis	0.000217	0.000704	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL1B—osteoporosis	0.000217	0.000704	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000212	0.000688	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.00021	0.000682	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ANXA2—osteoporosis	0.000208	0.000674	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLEK—osteoporosis	0.000208	0.000674	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRS2—osteoporosis	0.000207	0.000672	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000207	0.000671	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IRS2—osteoporosis	0.000204	0.000661	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOST—osteoporosis	0.000203	0.000658	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—osteoporosis	0.000196	0.000637	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	0.000195	0.000631	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—IL1B—osteoporosis	0.000195	0.000631	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	0.000194	0.000628	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PSMA5—osteoporosis	0.000192	0.000624	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PSMA2—osteoporosis	0.000192	0.000624	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRAK3—osteoporosis	0.000192	0.000622	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	0.000191	0.00062	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—osteoporosis	0.000188	0.000609	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—osteoporosis	0.000184	0.000598	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	0.000184	0.000598	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTH1R—osteoporosis	0.000183	0.000595	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CALCR—osteoporosis	0.000183	0.000595	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoporosis	0.000181	0.000588	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRS1—osteoporosis	0.000181	0.000587	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00018	0.000583	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TLN1—osteoporosis	0.000179	0.000581	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IRS1—osteoporosis	0.000178	0.000577	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VCL—osteoporosis	0.000177	0.000573	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ACTG1—osteoporosis	0.000175	0.000569	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—osteoporosis	0.000174	0.000564	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	0.000172	0.000559	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6R—osteoporosis	0.00017	0.000551	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.00017	0.000551	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KL—osteoporosis	0.00017	0.00055	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6R—osteoporosis	0.000167	0.000542	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000165	0.000536	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.000164	0.000533	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KL—osteoporosis	0.000163	0.000528	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—osteoporosis	0.000162	0.000526	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—osteoporosis	0.000158	0.000511	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—osteoporosis	0.000156	0.000507	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	0.000156	0.000507	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—osteoporosis	0.000152	0.000491	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—osteoporosis	0.000151	0.00049	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAP1A—osteoporosis	0.000148	0.000479	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoporosis	0.000147	0.000477	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAP1A—osteoporosis	0.000146	0.000475	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MGLL—osteoporosis	0.000146	0.000473	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSK—osteoporosis	0.000145	0.000471	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—osteoporosis	0.000145	0.000469	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFATC1—osteoporosis	0.000143	0.000463	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LRP5—osteoporosis	0.000142	0.000461	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—osteoporosis	0.000141	0.000458	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000141	0.000456	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000138	0.000447	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LRP6—osteoporosis	0.000136	0.000441	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FGA—osteoporosis	0.000134	0.000434	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AGER—osteoporosis	0.000133	0.000432	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ADCY5—osteoporosis	0.000133	0.000431	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000133	0.00043	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—osteoporosis	0.000131	0.000425	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—osteoporosis	0.000129	0.000419	CbGpPWpGaD
Auranofin—ALB—Metabolism—FDPS—osteoporosis	0.000128	0.000416	CbGpPWpGaD
Auranofin—ALB—Metabolism—PKM—osteoporosis	0.000128	0.000416	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—osteoporosis	0.000127	0.000412	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—osteoporosis	0.000125	0.000406	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FGB—osteoporosis	0.000122	0.000395	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPD2—osteoporosis	0.000122	0.000394	CbGpPWpGaD
Auranofin—ALB—Metabolism—PGLS—osteoporosis	0.000122	0.000394	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSMA2—osteoporosis	0.000117	0.000378	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PSMA5—osteoporosis	0.000117	0.000378	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS2—osteoporosis	0.000116	0.000377	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TLN1—osteoporosis	0.000115	0.000373	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS2—osteoporosis	0.000112	0.000362	CbGpPWpGaD
Auranofin—ALB—Metabolism—PNP—osteoporosis	0.000111	0.000361	CbGpPWpGaD
Auranofin—ALB—Metabolism—ATIC—osteoporosis	0.000111	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	0.000109	0.000354	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000107	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS1—osteoporosis	0.000101	0.000329	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—osteoporosis	0.000101	0.000327	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—P4HB—osteoporosis	9.91e-05	0.000321	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KL—osteoporosis	9.87e-05	0.00032	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS1—osteoporosis	9.74e-05	0.000316	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTH—osteoporosis	9.64e-05	0.000313	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6R—osteoporosis	9.53e-05	0.000309	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAP1A—osteoporosis	9.47e-05	0.000307	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA2—osteoporosis	9.45e-05	0.000307	CbGpPWpGaD
Auranofin—ALB—Metabolism—OXCT1—osteoporosis	9.45e-05	0.000307	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR2—osteoporosis	9.39e-05	0.000305	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFATC1—osteoporosis	9.24e-05	0.0003	CbGpPWpGaD
Auranofin—ALB—Metabolism—MGLL—osteoporosis	9.21e-05	0.000299	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DKK1—osteoporosis	9.17e-05	0.000297	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WNT1—osteoporosis	8.83e-05	0.000286	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.69e-05	0.000282	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGA—osteoporosis	8.59e-05	0.000279	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTHLH—osteoporosis	7.99e-05	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BMP2—osteoporosis	7.99e-05	0.000259	CbGpPWpGaD
Auranofin—ALB—Metabolism—IDH2—osteoporosis	7.83e-05	0.000254	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGB—osteoporosis	7.82e-05	0.000253	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AGER—osteoporosis	7.76e-05	0.000252	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ADCY5—osteoporosis	7.74e-05	0.000251	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—osteoporosis	7.57e-05	0.000245	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSMA5—osteoporosis	7.54e-05	0.000245	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSMA2—osteoporosis	7.54e-05	0.000245	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—osteoporosis	7.44e-05	0.000241	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP27A1—osteoporosis	7.36e-05	0.000239	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACP5—osteoporosis	7.16e-05	0.000232	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.07e-05	0.000229	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CALCA—osteoporosis	7.03e-05	0.000228	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS2—osteoporosis	6.77e-05	0.000219	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.75e-05	0.000219	CbGpPWpGaD
Auranofin—ALB—Metabolism—TPI1—osteoporosis	6.66e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	6.42e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KL—osteoporosis	6.38e-05	0.000207	CbGpPWpGaD
Auranofin—ALB—Metabolism—P4HB—osteoporosis	6.26e-05	0.000203	CbGpPWpGaD
Auranofin—ALB—Metabolism—GAPDH—osteoporosis	6.15e-05	0.000199	CbGpPWpGaD
Auranofin—ALB—Metabolism—RAP1A—osteoporosis	5.99e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS1—osteoporosis	5.91e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6R—osteoporosis	5.55e-05	0.00018	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—osteoporosis	5.52e-05	0.000179	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.22e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADCY5—osteoporosis	5e-05	0.000162	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO1—osteoporosis	4.84e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SPP1—osteoporosis	4.84e-05	0.000157	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSMA5—osteoporosis	4.77e-05	0.000155	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSMA2—osteoporosis	4.77e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS2—osteoporosis	4.38e-05	0.000142	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—osteoporosis	4.28e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—osteoporosis	4.24e-05	0.000138	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—osteoporosis	4.22e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—osteoporosis	4.09e-05	0.000133	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP19A1—osteoporosis	3.87e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS1—osteoporosis	3.82e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—osteoporosis	3.68e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6R—osteoporosis	3.59e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—osteoporosis	3.54e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—osteoporosis	3.31e-05	0.000107	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADCY5—osteoporosis	3.16e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—osteoporosis	3.15e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—osteoporosis	2.91e-05	9.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—osteoporosis	2.47e-05	8.02e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—osteoporosis	2.33e-05	7.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—osteoporosis	2.13e-05	6.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—osteoporosis	2.12e-05	6.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—osteoporosis	1.6e-05	5.18e-05	CbGpPWpGaD
